Represents the amount accrued for awards.

No definition available.

Name:	hw_AmountAccruedForAwards
Namespace Prefix:	hw_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Represents the measurement period in days where the SARs vest if the stock price exceeds a minimum percentage of the stock price on the grant date.

+ References

No definition available.

+ Details

Name:	hw_AverageStockPricePeriod
Namespace Prefix:	hw_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	hw_CommitmentsAndContingenciesLineItems
Namespace Prefix:	hw_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Ending period for expected liability adjustment.

+ References

No definition available.

+ Details

Name:	hw_EndingPeriodForExpectedLiabilityAdjustment
Namespace Prefix:	hw_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the stock price as of the grant date.

+ References

No definition available.

+ Details

Name:	hw_GrantDateStockPrice
Namespace Prefix:	hw_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Represents the grants approved by the committee to Employees for cash settled stock appreciation rights.

+ References

No definition available.

+ Details

Name:	hw_GrantsApprovedByCommitteeToEmployeesForCashSettledStockAppreciationRights
Namespace Prefix:	hw_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the grants approved by the committee to Employees for cash settled stock appreciation rights that remain outstanding.

+ References

No definition available.

+ Details

Name:	hw_GrantsApprovedByCommitteeToEmployeesForCashSettledStockAppreciationRightsOutstanding
Namespace Prefix:	hw_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the percentage of the grant date stock price that must be achieved for the awards to vest.

+ References

No definition available.

+ Details

Name:	hw_PercentageOfStockPriceOnGrantDate
Namespace Prefix:	hw_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the threshold stock price which must be met for approved SARS grants to vest.

+ References

No definition available.

+ Details

Name:	hw_ThresholdStockPrice
Namespace Prefix:	hw_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 14.F)

-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

-Section F

+ Details

Name:	us-gaap_AllocatedShareBasedCompensationExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=hw_StockAppreciationRightsSARS2011AwardsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=hw_StockAppreciationRightsSARS2012AwardsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=us-gaap_StockAppreciationRightsSARSMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies (Details) (USD $) In Millions, except Per Share data, unless otherwise specified	6 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Sep. 30, 2011	Sep. 30, 2012
Stock Appreciation Rights (SARs)
Commitments and Contingencies
Compensation expense	$ 2.7	$ 4.2
Stock Appreciation Rights (SARs), 2011 Awards
Commitments and Contingencies
Grants approved by committee to employees for cash settled stock appreciation rights (in shares)			0.4
Grants approved by committee to employees for cash settled stock appreciation rights that remain outstanding (in shares)	0.1
Ending period for expected liability adjustment	September 30, 2015
Amount accrued for awards	0.9
Grant-date stock price (in dollars per share)	$ 3.81
Stock Appreciation Rights (SARS), 2012 Awards
Commitments and Contingencies
Grants approved by committee to employees for cash settled stock appreciation rights (in shares)				1.0
Grants approved by committee to employees for cash settled stock appreciation rights that remain outstanding (in shares)	0.3
Ending period for expected liability adjustment	September 30, 2016
Amount accrued for awards	$ 5.8
Grant-date stock price (in dollars per share)	$ 1.85
Average stock price period	60 days
Minimum \| Stock Appreciation Rights (SARS), 2012 Awards
Commitments and Contingencies
Percentage of stock price on grant date	135.00%
Threshold stock price at which SARS will vest (in dollars per share)	$ 2.50